United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · IEX Real-Time Price · USD
275.13
+4.68 (1.73%)
At close: May 31, 2024, 4:00 PM
273.99
-1.14 (-0.41%)
After-hours: May 31, 2024, 7:37 PM EDT
United Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for United Therapeutics stock have an average target of 307.9, with a low estimate of 240 and a high estimate of 400. The average target predicts an increase of 11.91% from the current stock price of 275.13.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for UTHR stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Buy | 5 | 5 | 4 | 5 | 5 | 7 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $280 → $300 | Buy | Maintains | $280 → $300 | +9.04% | May 21, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $218 → $240 | Hold | Maintains | $218 → $240 | -12.77% | May 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $375 → $400 | Buy | Maintains | $375 → $400 | +45.39% | May 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $300 | Strong Buy | Reiterates | $300 | +9.04% | May 2, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $309 → $325 | Buy | Maintains | $309 → $325 | +18.13% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
2.79B
from 2.33B
Increased by 19.96%
Revenue Next Year
3.01B
from 2.79B
Increased by 7.81%
EPS This Year
24.79
from 19.81
Increased by 25.16%
EPS Next Year
27.05
from 24.79
Increased by 9.11%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.1B | 3.6B | 3.7B | 4.5B | 5.2B |
| Avg | 2.8B | 3.0B | 3.2B | 3.4B | 3.6B |
| Low | 2.5B | 2.6B | 2.7B | 2.8B | 2.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 32.0% | 28.2% | 24.4% | 42.2% | 50.7% |
| Avg | 20.0% | 7.8% | 4.8% | 8.9% | 3.6% |
| Low | 9.0% | -8.1% | -8.7% | -12.6% | -16.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.33 | 39.53 | 31.99 | 28.21 | 25.60 |
| Avg | 24.79 | 27.05 | 26.73 | 27.13 | 24.87 |
| Low | 20.95 | 21.24 | 16.57 | 25.79 | 23.89 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 53.1% | 59.4% | 18.3% | 5.6% | -5.6% |
| Avg | 25.2% | 9.1% | -1.2% | 1.5% | -8.3% |
| Low | 5.8% | -14.3% | -38.7% | -3.5% | -11.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.